Raymond James & Associates’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $217K | Buy |
|
|||||
|
2024
Q2 | $210K | Sell |
|
|||||
|
2024
Q1 | $554K | Sell |
|
|||||
|
2023
Q4 | $1.24M | Sell |
|
|||||
|
2023
Q3 | $492K | Sell |
|
|||||
|
2023
Q2 | $552K | Sell |
|
|||||
|
2023
Q1 | $613K | Buy |
|
|||||
|
2022
Q4 | $798K | Buy |
|
|||||
|
2022
Q3 | $710K | Sell |
|
|||||
|
2022
Q2 | $616K | Buy |
|
|||||
|
2022
Q1 | $564K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $212K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $105K | Sell |
|
|||||
|
2016
Q2 | $118K | Sell |
|
|||||
|
2016
Q1 | $89K | Buy |
|